A malignant schwannoma, or malignant peripheral nerve sheath tumor (MPNST), is a rare and aggressive cancer arising from the protective lining of peripheral nerves
Over time, this leads to consistently higher drug levels, more side effects, and a pattern that can mimic overdosing
GLP-1s can greatly slow the progression of type 2 diabetes when used early, before beta-cell mass and function are lost, helping to preserve or potentially restore these cells
The 2023 International PCOS Guideline remains cautious about the role of GLP-1RAs: their core indications remain limited to weight management and metabolic risk control
Many real-world users weigh 180 to 220 lb, have a BMI in the high 20s to low 30s, and want to lose 20 to 40 lb
The bottom line At the end of the day, microdosing GLP-1s is just a buzzy way of talking about a different approach to GLP-1s namely, starting (and staying) at the right dose for you, even if its lower than what the manufacturer recommends